Regulatory Reforms Needed to Leverage Data for Precision Medicine

From: Health Data Management

If the Obama administration’s $215 million Precision Medicine Initiative is to succeed, policymakers must modernize the regulatory system to better enable big data analytics to be used in genomic research.

That’s the conclusion of a new white paper on genomics released by the Center for Data Innovation and Health IT Now Coalition, which provides recommendations to policymakers. As the National Institutes of Health develops an implementation plan for the initiative, which is due to President Obama in September, the paper stresses the need for active public-private partnerships in development of precision medicine.

Read Complete Article

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published.

Please Answer: *